πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 140 of 173

  1. US 7214784

    Protective antigens for the control of Ixodes species infestations

    Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7211252

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

    Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7211402

    Transcription factor coactivator protein, p/CIP

    Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7211192

    Hybrid organic-inorganic adsorbents

    Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7211599

    Use of etodolac to treat hyperplasia

    Expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7208579

    IL4 receptor antagonists for horse, dog and cat

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7208154

    Methods and compositions for the treatment of MHC-associated conditions

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7208478

    Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7204982

    Compositions and methods for treatment and detection of multiple cancers

    Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7205011

    Anti-inflammatory activity of a specific turmeric extract

    Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7204996

    Method of cancer treatment

    Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7202045

    Detection and treatment of cancers of the lung

    Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7198949

    Compositions and methods for altering the biodistribution of biological agents

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7199103

    Synthetic compounds and compositions with enhanced cell binding

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7199102

    Orally administered peptides synergize statin activity

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7199114

    Triterpene quaternary salts as biologically active surfactants

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7198788

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7195768

    Polyvalent immunogen

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7196119

    Development of new selective estrogen receptor modulators

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7196205

    Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7195911

    Mammalian cells that have increased proliferative capacity

    Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7193075

    Sequences upstream of the CARP gene, vectors containing them and uses thereof

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7192704

    Methods for detection and treatment of neural cancers

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7192735

    Phosphopantetheinyl transferases and uses thereof

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7192914

    Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7193034

    Synthetic peptides, conjugation reagents and methods

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7189865

    Thiomolybdate analogues and uses thereof

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7189828

    Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7189396

    Delivery system using mAb 3E10 and mutants and/or functional fragments thereof

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7186413

    Hydrogels and water soluble polymeric carriers for drug delivery

    Expires Mon Mar 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7183401

    NOEY2 gene compositions and methods of use

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7183065

    Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7183268

    2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7183095

    Cell culture system for synthesis of infectious hepatitis C virus

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7183388

    Anti-MUC-1 single chain antibodies for tumor targeting

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7179888

    Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7179588

    Assay for the detection of paclitaxel resistant cells in human tumors

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7179445

    Cobalamin conjugates useful as imaging and therapeutic agents

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7179894

    Combinatorial selection of oligonucleotide aptamers

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7179834

    Salinosporamides and methods for use thereof

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7175848

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7176019

    RICK3 nucleic acids and proteins

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7176201

    Modulation of anxiety through blockade of anandamide hydrolysis

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7176232

    Salinosporamides and methods for use thereof

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7176302

    Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7176233

    Salinosporamides and methods for use thereof

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7176179

    Selective induction of cell death by delivery of amino-terminal interleukin-1-Ξ± pro-piece polypeptide

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7176283

    Protease-activated receptor 3 and uses thereof

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.